You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 1, January 7, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Men's Health
 •Prostate Disease
 •Oncology
 •Prostate Cancer
 •Oncology, Other
 •Statistics and Research Methods
 •Diet
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Randomized Trials of Antioxidant Supplementation for Cancer Prevention

First Bias, Now Chance—Next, Cause

Peter H. Gann, MD, ScD

JAMA. 2009;301(1):102-103. Published online December 9, 2008 (doi:10.1001/jama.2008.863).

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In 1996, a wave of hope arose when the Nutritional Prevention of Cancer trial reported a 65% reduction in prostate cancer incidence in men receiving selenium supplementation.1 This came only 2 years after the ATBC ({alpha}-Tocopherol, Beta Carotene) Cancer Prevention Trial had reported a 35% reduction in prostate cancer occurrence among men taking vitamin E supplements.2 Suddenly, it appeared to make sense that this cancer could be prevented by bolstering antioxidant defenses in middle-aged and older men. Prostate cancer was not a prespecified end point in either trial, and although both results were based on post hoc analysis, randomization had worked and it seemed unlikely that the encouraging findings were due to confounding bias. Indeed, confounding stood as the likely explanation for discordance between the earlier beta carotene trials that failed to demonstrate any benefit and numerous observational studies reporting that men who consumed . . . [Full Text of this Article]

Author Affiliation: Department of Pathology, University of Illinois at Chicago.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Selenium and Vitamin E Supplementation for Cancer Prevention—Reply
Scott M. Lippman, Eric A. Klein, and Phyllis J. Goodman
JAMA. 2009;301(18):1877.
EXTRACT | FULL TEXT  

Antioxidant Supplementation and Cancer Prevention
Maarten C. Bosland and David L. McCormick
JAMA. 2009;301(18):1877-1878.
EXTRACT | FULL TEXT  

Antioxidant Supplementation and Cancer Prevention
Paul F. Pinsky
JAMA. 2009;301(18):1878.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Vitamins E and C in the Prevention of Prostate and Total Cancer in Men: The Physicians' Health Study II Randomized Controlled Trial
J. Michael Gaziano, Robert J. Glynn, William G. Christen, Tobias Kurth, Charlene Belanger, Jean MacFadyen, Vadim Bubes, JoAnn E. Manson, Howard D. Sesso, and Julie E. Buring
JAMA. 2009;301(1):52-62.
ABSTRACT | FULL TEXT  

Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Scott M. Lippman, Eric A. Klein, Phyllis J. Goodman, M. Scott Lucia, Ian M. Thompson, Leslie G. Ford, Howard L. Parnes, Lori M. Minasian, J. Michael Gaziano, Jo Ann Hartline, J. Kellogg Parsons, James D. Bearden, III, E. David Crawford, Gary E. Goodman, Jaime Claudio, Eric Winquist, Elise D. Cook, Daniel D. Karp, Philip Walther, Michael M. Lieber, Alan R. Kristal, Amy K. Darke, Kathryn B. Arnold, Patricia A. Ganz, Regina M. Santella, Demetrius Albanes, Philip R. Taylor, Jeffrey L. Probstfield, T. J. Jagpal, John J. Crowley, Frank L. Meyskens, Jr, Laurence H. Baker, and Charles A. Coltman, Jr
JAMA. 2009;301(1):39-51.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cancer Prevention: From 1727 to Milestones of the Past 100 Years
Lippman and Hawk
Cancer Res. 2009;69:5269-5284.
ABSTRACT | FULL TEXT  

Cancer Prevention Research: Back to the Future
Lippman
Cancer Prevention Research 2009;2:503-513.
FULL TEXT  

Selenium and Vitamin E Supplementation for Cancer Prevention--Reply
Lippman et al.
JAMA 2009;301:1877-1877.
FULL TEXT  

Antioxidant Supplementation and Cancer Prevention
Pinsky
JAMA 2009;301:1878-1878.
FULL TEXT  

Antioxidant Supplementation and Cancer Prevention
Bosland and McCormick
JAMA 2009;301:1877-1878.
FULL TEXT  

Selenium and Vitamin E: Interesting Biology and Dashed Hope
Klein
JNCI J Natl Cancer Inst 2009;101:283-285.
FULL TEXT  

Antioxidants: SELECTed out?
Block
Integr Cancer Ther 2009;8:5-8.
 

Vitamin Supplementation and Prostate Cancer
JWatch General 2009;2009:1-1.
FULL TEXT  

Prostate Cancer Prevention: The Role of 5-alpha-reductase Inhibitors
Kramer
Am Soc Clin Oncol Ed Book 2009;2009:65-69.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.